메뉴 건너뛰기




Volumn 50, Issue 9, 1999, Pages 1173-1177

Alzheimer's disease and its management in the year 2010

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; CHOLINERGIC RECEPTOR STIMULATING AGENT; CHOLINESTERASE INHIBITOR; MELATONIN; NEUROPROTECTIVE AGENT; NONSTEROID ANTIINFLAMMATORY AGENT;

EID: 0032821133     PISSN: 10752730     EISSN: None     Source Type: Journal    
DOI: 10.1176/ps.50.9.1173     Document Type: Article
Times cited : (44)

References (36)
  • 2
    • 0024317904 scopus 로고
    • Prevalence of Alzheimer's disease in a community population of older persons: Higher than previously reported
    • Evans DA, Funkenstein HH, Albert MS, et al: Prevalence of Alzheimer's disease in a community population of older persons: higher than previously reported. JAMA 262:2551-2556, 1989
    • (1989) JAMA , vol.262 , pp. 2551-2556
    • Evans, D.A.1    Funkenstein, H.H.2    Albert, M.S.3
  • 3
    • 0023628422 scopus 로고
    • The prevalence of dementia: A quantitative integration of the literature
    • Jorm AF, Korten AE, Henderson AS: The prevalence of dementia: a quantitative integration of the literature. Acta Psychiatrica Scandinavica 76:465-479, 1987
    • (1987) Acta Psychiatrica Scandinavica , vol.76 , pp. 465-479
    • Jorm, A.F.1    Korten, A.E.2    Henderson, A.S.3
  • 4
    • 0027441436 scopus 로고
    • Functional status, education, and the diagnosis of dementia in the Shanghai survey
    • Hill LR, Klauber MR, Salmon DP, et al: Functional status, education, and the diagnosis of dementia in the Shanghai survey. Neurology 43:138-145, 1993
    • (1993) Neurology , vol.43 , pp. 138-145
    • Hill, L.R.1    Klauber, M.R.2    Salmon, D.P.3
  • 5
    • 0027389516 scopus 로고
    • Education and the prevalence of dementia and Alzheimer's disease
    • Katzman R: Education and the prevalence of dementia and Alzheimer's disease. Neurology 43:13-20, 1993
    • (1993) Neurology , vol.43 , pp. 13-20
    • Katzman, R.1
  • 6
    • 84942481063 scopus 로고
    • Influence of education and occupation on the incidence of Alzheimer's disease
    • Stern Y, Gurland B, Tatemichi TK, et al: Influence of education and occupation on the incidence of Alzheimer's disease. JAMA 271:1004-1010, 1994
    • (1994) JAMA , vol.271 , pp. 1004-1010
    • Stern, Y.1    Gurland, B.2    Tatemichi, T.K.3
  • 7
    • 0030967165 scopus 로고    scopus 로고
    • A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease
    • Sano M, Ernesto C, Thomas RG, et al: A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. New England Journal of Medicine 336:1216-1222, 1997
    • (1997) New England Journal of Medicine , vol.336 , pp. 1216-1222
    • Sano, M.1    Ernesto, C.2    Thomas, R.G.3
  • 8
    • 0031842292 scopus 로고    scopus 로고
    • Metrifonate treatment of the cognitive deficits in Alzheimer's disease
    • Cummings JL, Cyrus PA, Bieber F, et al: Metrifonate treatment of the cognitive deficits in Alzheimer's disease. Neurology 50:1214-1221, 1998
    • (1998) Neurology , vol.50 , pp. 1214-1221
    • Cummings, J.L.1    Cyrus, P.A.2    Bieber, F.3
  • 9
    • 0026792979 scopus 로고
    • A controlled trial of tacrine in Alzheimer's disease
    • Farlow M, Gracon SI, Hershey LA, et al: A controlled trial of tacrine in Alzheimer's disease. JAMA 268:2523-2529, 1992
    • (1992) JAMA , vol.268 , pp. 2523-2529
    • Farlow, M.1    Gracon, S.I.2    Hershey, L.A.3
  • 10
    • 10244259208 scopus 로고    scopus 로고
    • The efficacy and safety of donepezil in patients with Alzheimer's disease: Results of a US multicenter, randomized, double-blind, placebo-controlled trial
    • Rogers SL, Friedhoff LT, and the Donepezil Study Group: The efficacy and safety of donepezil in patients with Alzheimer's disease: results of a US multicenter, randomized, double-blind, placebo-controlled trial. Dementia 7:293-303, 1996
    • (1996) Dementia , vol.7 , pp. 293-303
    • Rogers, S.L.1    Friedhoff, L.T.2
  • 11
    • 0023767762 scopus 로고
    • Do general practitioners miss dementia in elderly patients?
    • O'Connor DW, Pollitt PA, Hyde JB, et al: Do general practitioners miss dementia in elderly patients? British Medical Journal 297:1107-1110, 1988
    • (1988) British Medical Journal , vol.297 , pp. 1107-1110
    • O'Connor, D.W.1    Pollitt, P.A.2    Hyde, J.B.3
  • 12
    • 0028919903 scopus 로고
    • Documentation and evaluation of cognitive impairment in elderly primary care patients
    • Callahan CM, Hendrie HC, Tierney WM: Documentation and evaluation of cognitive impairment in elderly primary care patients. Annals of Internal Medicine 122:422-429, 1995
    • (1995) Annals of Internal Medicine , vol.122 , pp. 422-429
    • Callahan, C.M.1    Hendrie, H.C.2    Tierney, W.M.3
  • 13
    • 0021271971 scopus 로고
    • Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA work group under the auspices of department of health and human services task force on Alzheimer's disease
    • McKhann G, Drachman D, Folstein M, et al: Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34:939-944, 1984
    • (1984) Neurology , vol.34 , pp. 939-944
    • McKhann, G.1    Drachman, D.2    Folstein, M.3
  • 14
    • 0027980815 scopus 로고
    • Clinical-neuropathological correlations in Alzheimer's disease and related dementias
    • Galasko D, Hansen LA, Katzman R, et al: Clinical-neuropathological correlations in Alzheimer's disease and related dementias. Archives of Neurology 51:888-895, 1994
    • (1994) Archives of Neurology , vol.51 , pp. 888-895
    • Galasko, D.1    Hansen, L.A.2    Katzman, R.3
  • 16
    • 0029021217 scopus 로고
    • Do nonsteroidal anti-inflammatory drugs decrease the risk for Alzheimer's disease? The Rotterdam study
    • Andersen K, Launer LJ, Ott AA, et al: Do nonsteroidal anti-inflammatory drugs decrease the risk for Alzheimer's disease? The Rotterdam study. Neurology 45:1441-1445, 1995
    • (1995) Neurology , vol.45 , pp. 1441-1445
    • Andersen, K.1    Launer, L.J.2    Ott, A.A.3
  • 17
    • 0029811901 scopus 로고    scopus 로고
    • Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: A review of 17 epidemiologic studies
    • McGeer PL, Schulzer M, McGeer EG: Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: a review of 17 epidemiologic studies. Neurology 47:425-432, 1996
    • (1996) Neurology , vol.47 , pp. 425-432
    • McGeer, P.L.1    Schulzer, M.2    McGeer, E.G.3
  • 18
    • 0031902295 scopus 로고    scopus 로고
    • Alzheimer's disease: Etiologies, pathophysiology, cognitive reserve, and treatment opportunities
    • Cummings JL, Vinters HV, Cole GM, et al: Alzheimer's disease: etiologies, pathophysiology, cognitive reserve, and treatment opportunities. Neurology 51(suppl 1):S2-S17, 1998
    • (1998) Neurology , vol.51 , Issue.SUPPL. 1
    • Cummings, J.L.1    Vinters, H.V.2    Cole, G.M.3
  • 19
    • 0026597063 scopus 로고
    • Alzheimer's disease: The amyloid cascade hypothesis
    • Hardy JA, Higgins GA: Alzheimer's disease: the amyloid cascade hypothesis. Science 256:184-185, 1992
    • (1992) Science , vol.256 , pp. 184-185
    • Hardy, J.A.1    Higgins, G.A.2
  • 20
    • 0025949464 scopus 로고
    • Mild cognitive impairment in the elderly: Predictors of dementia
    • Flicker C, Ferris SH, Reisberg B: Mild cognitive impairment in the elderly: predictors of dementia. Neurology 41:1006-1009, 1991
    • (1991) Neurology , vol.41 , pp. 1006-1009
    • Flicker, C.1    Ferris, S.H.2    Reisberg, B.3
  • 22
    • 0028952008 scopus 로고
    • The "preclinical phase" of probable Alzheimer's disease
    • Linn RT, Wolf PA, Bachman DL, et al: The "preclinical phase" of probable Alzheimer's disease. Archives of Neurology 52:485-490, 1995
    • (1995) Archives of Neurology , vol.52 , pp. 485-490
    • Linn, R.T.1    Wolf, P.A.2    Bachman, D.L.3
  • 23
    • 0029982042 scopus 로고    scopus 로고
    • Prediction of probable Alzheimer's disease in memory-impaired patients: A prospective longitudinal study
    • Teirney MC, Szalai JP, Snow WG, et al: Prediction of probable Alzheimer's disease in memory-impaired patients: a prospective longitudinal study. Neurology 46:661-665, 1996
    • (1996) Neurology , vol.46 , pp. 661-665
    • Teirney, M.C.1    Szalai, J.P.2    Snow, W.G.3
  • 24
    • 0023297731 scopus 로고
    • Institutionalization of Alzheimer's disease patients: Reducing precipitating factors through family counseling
    • Ferris SH, Steinberg G, Shulman E, et al: Institutionalization of Alzheimer's disease patients: reducing precipitating factors through family counseling. Home Health Care Services Quarterly 8(1):23-51, 1987
    • (1987) Home Health Care Services Quarterly , vol.8 , Issue.1 , pp. 23-51
    • Ferris, S.H.1    Steinberg, G.2    Shulman, E.3
  • 25
    • 0030428313 scopus 로고    scopus 로고
    • Behavioral and psychological signs and symptoms of dementia: A consensus statement on current knowledge and implications for research and treatment
    • Finkel SI, Coste e Silva J, Cohen G, et al: Behavioral and psychological signs and symptoms of dementia: a consensus statement on current knowledge and implications for research and treatment. International Psychogeriatrics 8:497-500, 1996
    • (1996) International Psychogeriatrics , vol.8 , pp. 497-500
    • Finkel, S.I.1    Coste E Silva, J.2    Cohen, G.3
  • 26
    • 0031941259 scopus 로고    scopus 로고
    • Assessing the impact of neuropsychiatric symptoms in Alzheimer's disease: The neuropsychiatry inventory caregiver distress scale
    • Kaufer DI, Cummings JL, Christine D, et al: Assessing the impact of neuropsychiatric symptoms in Alzheimer's disease: the Neuropsychiatry Inventory Caregiver Distress Scale. Journal of the American Geriatrics Society 46:210-215, 1998
    • (1998) Journal of the American Geriatrics Society , vol.46 , pp. 210-215
    • Kaufer, D.I.1    Cummings, J.L.2    Christine, D.3
  • 27
    • 0019991994 scopus 로고
    • The impact of dementia on the family
    • Rabins PV, Mace NL, Lucan MJ: The impact of dementia on the family. JAMA 248:333-335, 1982
    • (1982) JAMA , vol.248 , pp. 333-335
    • Rabins, P.V.1    Mace, N.L.2    Lucan, M.J.3
  • 28
    • 0029887389 scopus 로고    scopus 로고
    • The spectrum of behavioral changes in Alzheimer's disease
    • Mega MS, Cummings JL, Fiorello T, et al: The spectrum of behavioral changes in Alzheimer's disease. Neurology 46:130-135, 1996
    • (1996) Neurology , vol.46 , pp. 130-135
    • Mega, M.S.1    Cummings, J.L.2    Fiorello, T.3
  • 29
    • 0024601769 scopus 로고
    • Overview of depression and psychosis in Alzheimer's disease
    • Wragg R, Jeste DV: Overview of depression and psychosis in Alzheimer's disease. American Journal of Psychiatry 146:577-587, 1989
    • (1989) American Journal of Psychiatry , vol.146 , pp. 577-587
    • Wragg, R.1    Jeste, D.V.2
  • 30
    • 0026502161 scopus 로고
    • Cognitive deficits of patients with Alzheimer's disease with and without delusions
    • Jeste DV, Wragg RE, Salmon DP, et al: Cognitive deficits of patients with Alzheimer's disease with and without delusions. American Journal of Psychiatry 149:184-189, 1992
    • (1992) American Journal of Psychiatry , vol.149 , pp. 184-189
    • Jeste, D.V.1    Wragg, R.E.2    Salmon, D.P.3
  • 33
    • 0006079706 scopus 로고
    • Emotional reactions of Alzheimer's caregivers in support group settings
    • Shulman E, Steinberg G: Emotional reactions of Alzheimer's caregivers in support group settings. Gerontologist 24:158, 1984
    • (1984) Gerontologist , vol.24 , pp. 158
    • Shulman, E.1    Steinberg, G.2
  • 34
    • 0030902127 scopus 로고    scopus 로고
    • Effects of xanomeline, a selective muscarinic receptor agonist, on cognitive function and behavioral symptoms in Alzheimer disease
    • Bodick NC, Offen WW, Levey AI, et al: Effects of xanomeline, a selective muscarinic receptor agonist, on cognitive function and behavioral symptoms in Alzheimer disease. Archives of Neurology 54:465-473, 1997
    • (1997) Archives of Neurology , vol.54 , pp. 465-473
    • Bodick, N.C.1    Offen, W.W.2    Levey, A.I.3
  • 36
    • 0030851210 scopus 로고    scopus 로고
    • Effect of tacrine on language, praxis, and noncognitive behavioral problems in Alzheimer disease
    • Raskind MA, Sadowsky CH, Sigmund WR, et al: Effect of tacrine on language, praxis, and noncognitive behavioral problems in Alzheimer disease. Archives of Neurology 54:836-840, 1997
    • (1997) Archives of Neurology , vol.54 , pp. 836-840
    • Raskind, M.A.1    Sadowsky, C.H.2    Sigmund, W.R.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.